WST Q4 Earnings Preview: Can HVP Momentum Continue to Drive Margins?

West Pharmaceutical heads into Q4 with HVP demand likely lifting margins, but tariff risk looms as revenue and EPS targets come into focus.

Zacks Investment Research • 4 hours ago

West Pharmaceutical Services (WST) Earnings Expected to Grow: Should You Buy?

West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Feb 5, 2026

West Pharmaceutical Services, Inc. (WST) Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity Transcript

West Pharmaceutical Services, Inc. (WST) Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity Transcript

Seeking Alpha • Feb 5, 2026

Here's Why West Pharmaceutical (WST) Is a Great 'Buy the Bottom' Stock Now

West Pharmaceutical (WST) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Zacks Investment Research • Jan 30, 2026

West to Host Fourth-Quarter and Full-Year 2025 Conference Call

EXTON, Pa., Jan. 29, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2025 financial results before the market opens on Thursday, February 12, 2026, and will follow with a conference call to discuss the results and business expectations at 8:00 a.m. Eastern Time.

PRNewsWire • Jan 29, 2026

COO vs. WST: Which Stock Should Value Investors Buy Now?

Investors with an interest in Medical - Dental Supplies stocks have likely encountered both The Cooper Companies (COO) and West Pharmaceutical Services (WST). But which of these two stocks is more attractive to value investors?

Zacks Investment Research • Jan 28, 2026

Time To Buy The Dip In West Pharmaceutical Stock?

West Pharmaceutical Services (WST) stock should be included in your watchlist. Here's why – it is currently operating within the support zone ($224.83 – $248.49), prices from which it has previously bounced significantly.

Forbes • Jan 26, 2026

Conestoga Mid Cap Composite Q4 2025 Leaders And Laggards

The coming week will put Big Tech earnings and the Federal Reserve firmly in focus, with markets bracing for key signals on growth, inflation, and policy direction.

Seeking Alpha • Jan 25, 2026

WST Launches Synchrony S1 Prefillable Syringe at Pharmapack

West Pharmaceutical debuts the Synchrony S1 prefillable syringe at Pharmapack 2026, enhancing biologics, vaccines and home-care support.

Zacks Investment Research • Jan 23, 2026

All You Need to Know About West Pharmaceutical (WST) Rating Upgrade to Strong Buy

West Pharmaceutical (WST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks Investment Research • Jan 22, 2026